Cargando…
A Novel Hydroxamate-Based Compound WMJ-J-09 Causes Head and Neck Squamous Cell Carcinoma Cell Death via LKB1-AMPK-p38MAPK-p63-Survivin Cascade
Growing evidence shows that hydroxamate-based compounds exhibit broad-spectrum pharmacological properties including anti-tumor activity. However, the precise mechanisms underlying hydroxamate derivative-induced cancer cell death remain incomplete understood. In this study, we explored the anti-tumor...
Autores principales: | Yen, Chia-Sheng, Choy, Cheuk-Sing, Huang, Wei-Jan, Huang, Shiu-Wen, Lai, Pin-Ye, Yu, Meng-Chieh, Shiue, Ching, Hsu, Ya-Fen, Hsu, Ming-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837967/ https://www.ncbi.nlm.nih.gov/pubmed/29545751 http://dx.doi.org/10.3389/fphar.2018.00167 |
Ejemplares similares
-
WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling Cascade
por: Huang, Shiu-Wen, et al.
Publicado: (2019) -
Lovastatin‐mediated MCF‐7 cancer cell death involves LKB1‐AMPK‐p38MAPK‐p53‐survivin signalling cascade
por: Huang, Shiu‐Wen, et al.
Publicado: (2019) -
The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death
por: Huang, Yu-Han, et al.
Publicado: (2015) -
Lovastatin causes FaDu hypopharyngeal carcinoma cell death via AMPK-p63-survivin signaling cascade
por: Yen, Chia-Sheng, et al.
Publicado: (2016) -
WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1
por: Chang, Yi-Fang, et al.
Publicado: (2014)